Pricing
Login
Home
Charts
Search
Watchlist
Products

Solara Active Pharma Sciences Ltd

SOLARA
₹628.25-1.93%20 Nov 2026
Reports
Pharma API

Solara Active Pharma Sciences Ltd

SOLARA
₹628.25
-1.93%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹3,050Cr
Close
Close Price
₹628.25
Industry
Industry
Pharma API
PE
Price To Earnings
82.02
PS
Price To Sales
1.99
Revenue
Revenue
₹1,535Cr
Rev Gr TTM
Revenue Growth TTM
27.30%
PAT Gr TTM
PAT Growth TTM
476.29%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
212299363347300273319314349387382417
Growth YoY
Revenue Growth YoY%
-46.3-21.33.2-18.441.7-8.8-12.2-9.616.241.919.633.1
Expenses
ExpensesCr
374290322286243228262279312330320341
Operating Profit
Operating ProfitCr
-1621042615845573537586277
OPM
OPM%
-76.33.311.517.719.216.617.911.110.714.916.218.4
Other Income
Other IncomeCr
-62-120101610-763-4
Interest Expense
Interest ExpenseCr
253131282729242122282218
Depreciation
DepreciationCr
262525252524242426262727
PBT
PBTCr
-275-167-1388-211-10-17101628
Tax
TaxCr
0890000000000
PAT
PATCr
-275-255-1388-211-10-17101628
Growth YoY
PAT Growth YoY%
-64,132.6-6,893.929.6146.9102.999.2178.2-226.1-315.4557.155.0381.8
NPM
NPM%
-129.9-85.3-3.72.32.7-0.83.3-3.2-5.02.54.36.8
EPS
EPS₹
-66.4-65.4-3.52.52.0-0.92.5-2.4-4.02.23.55.9
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
212299363347300273319314349387382417
Growth YoY
Revenue Growth YoY%
-46.3-21.33.2-18.441.7-8.8-12.2-9.616.241.919.633.1
Expenses
ExpensesCr
374290322286243228262279312330320341
Operating Profit
Operating ProfitCr
-1621042615845573537586277
OPM
OPM%
-76.33.311.517.719.216.617.911.110.714.916.218.4
Other Income
Other IncomeCr
-62-120101610-763-4
Interest Expense
Interest ExpenseCr
253131282729242122282218
Depreciation
DepreciationCr
262525252524242426262727
PBT
PBTCr
-275-167-1388-211-10-17101628
Tax
TaxCr
0890000000000
PAT
PATCr
-275-255-1388-211-10-17101628
Growth YoY
PAT Growth YoY%
-64,132.6-6,893.929.6146.9102.999.2178.2-226.1-315.4557.155.0381.8
NPM
NPM%
-129.9-85.3-3.72.32.7-0.83.3-3.2-5.02.54.36.8
EPS
EPS₹
-66.4-65.4-3.52.52.0-0.92.5-2.4-4.02.23.55.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5211,3871,3221,6171,2681,4441,2891,2841,3691,535
Growth
Revenue Growth%
166.2-4.722.3-21.613.8-10.7-0.46.627.3
Expenses
ExpensesCr
4581,1661,0621,2311,1881,3101,3841,0771,1821,301
Operating Profit
Operating ProfitCr
6222125938680134-95206187234
OPM
OPM%
12.015.919.623.96.39.3-7.416.113.615.2
Other Income
Other IncomeCr
21228291723-18580-2
Interest Expense
Interest ExpenseCr
2582788475901051159589
Depreciation
DepreciationCr
34839410911211110399100105
PBT
PBTCr
668115222-91-45-4881-737
Tax
TaxCr
0100-33-2379000
PAT
PATCr
667115221-58-22-5671-737
Growth
PAT Growth%
1,024.370.793.3-126.361.8-2,448.1100.1-1,472.2476.3
NPM
NPM%
1.14.88.713.7-4.6-1.5-44.00.0-0.52.4
EPS
EPS₹
0.320.140.863.6-14.9-5.7-145.30.1-1.77.7
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5211,3871,3221,6171,2681,4441,2891,2841,3691,535
Growth
Revenue Growth%
166.2-4.722.3-21.613.8-10.7-0.46.627.3
Expenses
ExpensesCr
4581,1661,0621,2311,1881,3101,3841,0771,1821,301
Operating Profit
Operating ProfitCr
6222125938680134-95206187234
OPM
OPM%
12.015.919.623.96.39.3-7.416.113.615.2
Other Income
Other IncomeCr
21228291723-18580-2
Interest Expense
Interest ExpenseCr
2582788475901051159589
Depreciation
DepreciationCr
34839410911211110399100105
PBT
PBTCr
668115222-91-45-4881-737
Tax
TaxCr
0100-33-2379000
PAT
PATCr
667115221-58-22-5671-737
Growth
PAT Growth%
1,024.370.793.3-126.361.8-2,448.1100.1-1,472.2476.3
NPM
NPM%
1.14.88.713.7-4.6-1.5-44.00.0-0.52.4
EPS
EPS₹
0.320.140.863.6-14.9-5.7-145.30.1-1.77.7
Sales CAGR
1 Year7%
3 Years-2%
5 Years-3%
TTM27%
EBITDA CAGR
1 Year-9%
3 Years12%
5 Years-14%
TTM20%
PAT CAGR
1 Year-
3 Years-
5 Years-
TTM476%
Avg. ROCE
1 Year5%
3 Years-3%
5 Years-2%
TTM6%
CFO / EBITDA
1 Year82%
3 Years159%
5 Years76%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
25262736363636404548
Reserves
ReservesCr
7398269631,5531,4891,4648981,0541,2081,388
Current Liabilities
Current LiabilitiesCr
7386567307891,0631,1011,243944894766
Non Current Liabilities
Non Current LiabilitiesCr
315344333232354296172191183250
Total Liabilities
Total LiabilitiesCr
1,8221,9602,1542,6142,9452,8992,3512,2322,3332,454
Current Assets
Current AssetsCr
6086486721,0581,2391,1888017298581,009
Non Current Assets
Non Current AssetsCr
1,2141,3121,4821,5561,7061,7121,5501,5031,4741,445
Total Assets
Total AssetsCr
1,8221,9602,1542,6142,9452,8992,3512,2322,3332,454
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
25262736363636404548
Reserves
ReservesCr
7398269631,5531,4891,4648981,0541,2081,388
Current Liabilities
Current LiabilitiesCr
7386567307891,0631,1011,243944894766
Non Current Liabilities
Non Current LiabilitiesCr
315344333232354296172191183250
Total Liabilities
Total LiabilitiesCr
1,8221,9602,1542,6142,9452,8992,3512,2322,3332,454
Current Assets
Current AssetsCr
6086486721,0581,2391,1888017298581,009
Non Current Assets
Non Current AssetsCr
1,2141,3121,4821,5561,7061,7121,5501,5031,4741,445
Total Assets
Total AssetsCr
1,8221,9602,1542,6142,9452,8992,3512,2322,3332,454

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
49166242155-242156109213153
Investing Cash Flow
Investing Cash FlowCr
-85-116-359-106-243-81-4-37-99
Financing Cash Flow
Financing Cash FlowCr
68-239792334-113-106-180-54
Net Cash Flow
Net Cash FlowCr
3127-20142-151-380-41
Free Cash Flow
Free Cash FlowCr
14167243158-242158110213153
CFO To PAT
CFO To PAT%
824.9247.9211.470.2415.2-702.3-19.239,411.1-2,063.6
CFO To EBITDA
CFO To EBITDA%
78.875.393.340.3-302.6116.7-114.4103.281.9
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
49166242155-242156109213153
Investing Cash Flow
Investing Cash FlowCr
-85-116-359-106-243-81-4-37-99
Financing Cash Flow
Financing Cash FlowCr
68-239792334-113-106-180-54
Net Cash Flow
Net Cash FlowCr
3127-20142-151-380-41
Free Cash Flow
Free Cash FlowCr
14167243158-242158110213153
CFO To PAT
CFO To PAT%
824.9247.9211.470.2415.2-702.3-19.239,411.1-2,063.6
CFO To EBITDA
CFO To EBITDA%
78.875.393.340.3-302.6116.7-114.4103.281.9

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,0801,1905,0102,3941,1821,3412,0051,8663,050
Price To Earnings
Price To Earnings
18.110.422.63,943.882.0
Price To Sales
Price To Sales
0.80.93.11.90.81.01.61.42.0
Price To Book
Price To Book
1.31.23.11.60.81.41.91.52.1
EV To EBITDA
EV To EBITDA
6.56.714.142.316.3-24.613.613.415.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
31.736.842.044.333.331.619.638.636.036.0
OPM
OPM%
12.015.919.623.96.39.3-7.416.113.615.2
NPM
NPM%
1.14.88.713.7-4.6-1.5-44.00.0-0.52.4
ROCE
ROCE%
2.311.612.113.8-0.61.8-19.76.14.56.3
ROE
ROE%
0.87.911.613.9-3.8-1.5-60.70.1-0.62.6
ROA
ROA%
0.33.45.38.5-2.0-0.8-24.10.0-0.31.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,0801,1905,0102,3941,1821,3412,0051,8663,050
Price To Earnings
Price To Earnings
18.110.422.63,943.882.0
Price To Sales
Price To Sales
0.80.93.11.90.81.01.61.42.0
Price To Book
Price To Book
1.31.23.11.60.81.41.91.52.1
EV To EBITDA
EV To EBITDA
6.56.714.142.316.3-24.613.613.415.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
31.736.842.044.333.331.619.638.636.036.0
OPM
OPM%
12.015.919.623.96.39.3-7.416.113.615.2
NPM
NPM%
1.14.88.713.7-4.6-1.5-44.00.0-0.52.4
ROCE
ROCE%
2.311.612.113.8-0.61.8-19.76.14.56.3
ROE
ROE%
0.87.911.613.9-3.8-1.5-60.70.1-0.62.6
ROA
ROA%
0.33.45.38.5-2.0-0.8-24.10.0-0.31.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr4,5904,4324,4223,0501,3381,313795
Close PriceClose₹352.70473.25484.50628.2525.17446.1579.28
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE213.7637.3819.3482.0230.7025.0216.62
Price To SalesPS27.684.561.551.994.782.561.02
RevenueRevenueCr1669712,8511,535280513778
Revenue Growth TTMRev Gr TTM%13.0%15.1%27.3%-8.8%6.6%
PAT Growth TTMPAT Gr TTM%28.3%14.9%476.3%-55.3%23.4%
Market CapitalizationMkt CapCr4,5904,4324,4223,0501,3381,313795
Close PriceClose₹352.70473.25484.50628.2525.17446.1579.28
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE213.7637.3819.3482.0230.7025.0216.62
Price To SalesPS27.684.561.551.994.782.561.02
RevenueRevenueCr1669712,8511,535280513778
Revenue Growth TTMRev Gr TTM%13.0%15.1%27.3%-8.8%6.6%
PAT Growth TTMPAT Gr TTM%28.3%14.9%476.3%-55.3%23.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Jun 23
Mar 23
Jun 22
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Jun 23
Mar 23
Jun 22
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews